You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR MICRONASE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MICRONASE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00759720 ↗	Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.	Terminated	Takeda	Phase 3	2003-11-01	The purpose of this study is to determine the safety and efficacy of TAK-559, once daily (QD), combined with glyburide in treating Type 2 Diabetes.
NCT00770835 ↗	Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.	Completed	Takeda	Phase 4	2009-03-01	The purpose of this study is to determine the efficacy of pioglitazone compared to glibenclamide, once daily (QD), taken together with metformin and lifestyle modification in type 2 diabetic subjects with cardiovascular disease.
NCT01068860 ↗	To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies	Completed	Novartis	Phase 2	2010-02-01	This was a 10-week, placebo-controlled, randomized study to investigate the effect of injectable IL-1B antagonist, Canakinumab , in participants with impaired glucose tolerance or Type 2 Diabetes Mellitus (T2DM) already treated on different background diabetes therapies.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MICRONASE

Condition Name

Chart
Table

Condition Name for MICRONASE
Intervention	Trials
Diabetes Mellitus	2
Gestational Diabetes	1
Healthy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MICRONASE
Intervention	Trials
Diabetes Mellitus	3
Diabetes Mellitus, Type 2	2
Diabetes, Gestational	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MICRONASE

Trials by Country

Map
Table

Trials by Country for MICRONASE
Location	Trials
United States	9
Italy	8
India	7
Canada	2
Australia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MICRONASE
Location	Trials
Texas	2
North Dakota	1
Nebraska	1
Kentucky	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MICRONASE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MICRONASE
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MICRONASE
Clinical Trial Phase	Trials
Completed	4
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MICRONASE

Sponsor Name

Chart
Table

Sponsor Name for MICRONASE
Sponsor	Trials
Takeda	2
Novartis	1
United States Department of Defense	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MICRONASE
Sponsor	Trials
Industry	4
Other	4
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.